Table 1 Demographics of group on admission and relation to survival at 30 days

N

55

29 (53%)

26 (47%)

Age (years)

69 ± 11

69 ± 12

71 ± 11

ns

Gender

M 34, F 21

M 9, F21

M 10, F 10

ns

MAP (mmHg)

57 ± 3

57 ± 3

58 ± 2

ns

CI (L min⁻¹ M²)

2.09 ± 0.11

2.10 ± 0.10

2.04 ± 0.11

ns

HR (min⁻¹)

113 ± 8

112 ± 8

114 ± 6

ns

Ea (mmHg mL⁻¹)

2.11 ± 0.41

2.10 ± 0.36

2.15 ± 0.48

ns

Ees (mmHg mL⁻¹)

1.42 ± 0.35

1.36 ± 0.37

1.54 ± 0.33

ns

Ea/Ees

1.56 ± 0.41

1.67 ± 0.43

1.44 ± 0.39

ns

Pra (mmHg)

7.6 ± 1.4

7.5 ± 1.5

7.6 ± 1.3

ns

Pmsa (mmHg)

13.0 ± 1.4

12.9 ± 1.6

12.9 ± 1.3

ns

Pvr (mmHg)

5.3 ± 0.5

5.3 ± 0.5

5.3 ± 0.5

ns

Eh (%)

0.41 ± 0.05

0.42 ± 0.05

0.42 ± 0.05

ns

LV SW (mmHg mL)

2581 ± 900

2842 ± 740

2414 ± 1018

ns

LV efficiency (%)

0.65 ± 0.12

0.65 ± 0.12

0.63 ± 0.13

ns

Lactate (mmol L⁻¹)

5.1 ± 4.3

2.7 ± 1.5

7.1 ± 4.8

< 0.005

Hematocrit (%)

30.0 ± 4.3

30.0 ± 4.3

29.9 ± 4.5

ns

Hemoglobin (g dL⁻¹)

9.8 ± 1.4

9.8 ± 1.4

9.8 ± 1.4

ns

BUN (mg dL⁻¹)

38.8 ± 29.3

27.3 ± 15.2

49.7 ± 35.3

< 0.005

Creatinine (mg dL⁻¹)

1.8 ± 1.2

1.3 ± 0.9

2.2 ± 1.3

0.010

Chronic hypertension

26 (47%)

16 (55%)

10 (38%)

ns

SOFA score

16 ± 7

11 ± 5

21 ± 6

< 0.005

SAPS II score

63 ± 15

52 ± 12

74 ± 8

< 0.005